Breast Cancer Drug
- All
- News
- Videos
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
AstraZeneca India Gets Approval To Market Drug Treating Breast Cancer
Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.
-
Indian-Origin Woman Given Months To Live Now Cancer-Free After Drug Trial In UK
An Indian-origin woman, Jasmin David, who was given just months to live a few years ago is showed no evidence of breast cancer following a successful National Health Service (NHS) trial, doctors said.
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
US Court Slashes $8 Billion Verdict In Johnson & Johnson Drug Lawsuit
A Pennsylvania court on Friday slashed an $8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury because the company failed to warn that a psychiatric drug could cause breast growth in men.
-
Can DNA Tests Help Prescribe Antidepressants?
Doctors increasingly use information about genes to evaluate potential risk for some diseases, such as BRCA genes that are linked to breast cancer, and to determine the best drug treatment for diseases, including acute leukemia and HIV. But using pharmacogenetics to help treat depression remains controversial.
-
Breast Cancer Drugs Useful In Treating Drug-Resistant Lung Tumours
A class of drugs used to treat certain breast cancers could help tackle lung cancers that have become resistant to targeted therapies, suggests a study done on mice.
-
Breast Cancer Drug Linked To Brain Malfunction
Breast cancer is the top cancer in women worldwide and is increasing particularly in developing countries where a majority of cases are diagnosed in late stages.
-
Drug Combo Cuts Breast Cancer Deaths In Key Trial
Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
-
Exercise May Cut Bad Effects Of Breast Cancer Drugs: Study
New York: A combination of weight training and 150 minutes of moderate aerobic activity — such as brisk walking or jogging — every week may help mitigate the side-effects of hormone-therapy drugs that significantly reduce the risk of breast cancer recurrence in post-menopausal survivors, shows a recent study. Because most breast cancers are hor...
-
Depression Drug Cuts Joint Pain For Women With Breast Cancer: Study
New York: A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, says a study. The researches conducted a trial to test whether duloxetine, a depression and anxiety drug, could alleviate pain caused by aromatase inhibitors, a common breast cance...
-
Combo Therapy Against: Ovarian And Breast Cancer, Can Overcome Drug Resistance
Bolstering the know how behind targeted cancer treatment, Indian scientists have offered a new rationale for combination drug therapy for ovarian and breast cancer, which they say can counter drug resistance and reduce side-effects.
-
Glenmark, US-Based Particle Sciences To Develop Generic Cancer Drug
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
-
European Advisory Panel Recommends Nod For Pfizer Breast Cancer Drug
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
-
Biocon's Cancer Drug Accepted For Review, Shares Hit 52-Week High
Biocon shares jumped 5 per cent to their 52-week high on Friday after the drugmaker announced that the European regulator has accepted for review a breast cancer biosimilar jointly developed with Mylan. Biocon and American-Dutch Mylan are exclusive partners on a broad portfolio of biosimilars and insulin analogs.
-
AstraZeneca Pharma's Cancer-Treating Drug Gets Regulator's Nod In India
AstraZeneca Pharma India Ltd on Wednesday said it has received an approval from the Drug Controller General of India (DCGI) for the cancer drug trastuzumab deruxtecan for treatment of metastatic breast cancer.
-
AstraZeneca India Gets Approval To Market Drug Treating Breast Cancer
Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer.
-
Indian-Origin Woman Given Months To Live Now Cancer-Free After Drug Trial In UK
An Indian-origin woman, Jasmin David, who was given just months to live a few years ago is showed no evidence of breast cancer following a successful National Health Service (NHS) trial, doctors said.
-
Enhertu Sharply Improves Survival In Breast Cancer Patients: Report
A drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of people who can benefit from the treatment.
-
US Court Slashes $8 Billion Verdict In Johnson & Johnson Drug Lawsuit
A Pennsylvania court on Friday slashed an $8 billion ruling against US pharmaceutical giant Johnson & Johnson, imposed by a jury because the company failed to warn that a psychiatric drug could cause breast growth in men.
-
Can DNA Tests Help Prescribe Antidepressants?
Doctors increasingly use information about genes to evaluate potential risk for some diseases, such as BRCA genes that are linked to breast cancer, and to determine the best drug treatment for diseases, including acute leukemia and HIV. But using pharmacogenetics to help treat depression remains controversial.
-
Breast Cancer Drugs Useful In Treating Drug-Resistant Lung Tumours
A class of drugs used to treat certain breast cancers could help tackle lung cancers that have become resistant to targeted therapies, suggests a study done on mice.
-
Breast Cancer Drug Linked To Brain Malfunction
Breast cancer is the top cancer in women worldwide and is increasing particularly in developing countries where a majority of cases are diagnosed in late stages.
-
Drug Combo Cuts Breast Cancer Deaths In Key Trial
Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
-
Exercise May Cut Bad Effects Of Breast Cancer Drugs: Study
New York: A combination of weight training and 150 minutes of moderate aerobic activity — such as brisk walking or jogging — every week may help mitigate the side-effects of hormone-therapy drugs that significantly reduce the risk of breast cancer recurrence in post-menopausal survivors, shows a recent study. Because most breast cancers are hor...
-
Depression Drug Cuts Joint Pain For Women With Breast Cancer: Study
New York: A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, says a study. The researches conducted a trial to test whether duloxetine, a depression and anxiety drug, could alleviate pain caused by aromatase inhibitors, a common breast cance...
-
Combo Therapy Against: Ovarian And Breast Cancer, Can Overcome Drug Resistance
Bolstering the know how behind targeted cancer treatment, Indian scientists have offered a new rationale for combination drug therapy for ovarian and breast cancer, which they say can counter drug resistance and reduce side-effects.
-
Glenmark, US-Based Particle Sciences To Develop Generic Cancer Drug
Glenmark Pharmaceuticals on Monday said it has entered into an agreement with US-based Particle Sciences Inc to develop and market a generic version of Celgene's ABRAXANE, which is used in treatments of breast and lung cancers.
-
European Advisory Panel Recommends Nod For Pfizer Breast Cancer Drug
US drug maker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
-
Biocon's Cancer Drug Accepted For Review, Shares Hit 52-Week High
Biocon shares jumped 5 per cent to their 52-week high on Friday after the drugmaker announced that the European regulator has accepted for review a breast cancer biosimilar jointly developed with Mylan. Biocon and American-Dutch Mylan are exclusive partners on a broad portfolio of biosimilars and insulin analogs.
